Company profile
ERROR: The requested URL could not be retrieved
Ceryx Medical Limited is a UK company with status active founded in 2016 based in Wales.
Financial period: 1 Aug 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUxMjk4OTE0MGFkaXF6a2N4
Published 27 Mar 2026 14:18
Last confirmation statement made up date
Last accounts made up date
AA01 | Transaction MzQ0MTkwMTM1M2FkaXF6a2N4
Published 04 Nov 2024 02:16
AA01 | Transaction MzQzNjg2MTM1OWFkaXF6a2N4
Published 23 Sep 2024 02:34
Company registered at Companies House
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs). These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking.
Ceryx Medical develops devices designed to help restore certain bodily processes such as heart rate and walking through the use of a chip that mimics nerve centres.
N/A
1 Jan 2022 to 31 Mar 2023
Patients who undergo cardiac surgery often find their hearts struggle to supply enough blood to the body during the recovery period post-surgery. Ceryx have developed a unique pacing device which is able to boost the performance of the heart while also reducing the workload on the heart, which can help the heart to heal. In this project, Ceryx will trial ...
1 Apr 2020 to 30 Jun 2021
Ceryx Medical are developing the next generation of medical devices. Their patented bio-electronics allow them to develop closed-loop systems which are able to listen to the human body and respond to its needs, restoring function and treating disease. They have shown that their first device is able to significantly improve heart function in a model of hea...
1 Jan 2018 to 31 Mar 2019
We are developing a novel implantable medical electronic device for drug-free control of Blood Pressure. We are, therefore, addressing a major global health challenge as high Blood Pressure (hypertension) is a major cause of stroke, heart/kidney failure and dementia. 1-in-3 people are hypertensive, the prevalence being highest amongst the older population...
1 Jun 2016 to 28 Feb 2018
The Central Pattern Generator (CPG) implants, which we are developing, are a potentially disruptive medical science and technology solution enabling the effective bioelectronic treatment of a wide range of chronic diseases. Their first application will be within Cardiac Rhythm Management (CRM) market where their use will improve the life of patients, and ...
